Financials data is unavailable for this security.
View more
Year on year Remedent Inc was unable to grow net income despite reducing the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). In part this was due to revenues that fell from 1.60m to 1.06m.
| Gross margin | 65.38% |
|---|---|
| Net profit margin | -21.97% |
| Operating margin | -9.45% |
| Return on assets | -3.24% |
|---|---|
| Return on equity | -5.49% |
| Return on investment | -5.20% |
More ▼
Cash flow in USDView more
In 2020, Remedent Inc increased its cash reserves by 72.27%, or 48.09k. The company earned 101.55k from its operations for a Cash Flow Margin of 9.54%. In addition the company used on investing activities and also paid in financing cash flows.
| Cash flow per share | -0.0104 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.2367 |
|---|---|
| Tangible book value per share | 0.2366 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.2402 |
|---|---|
| Quick ratio | 0.2033 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -140.32%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -112.64 |
